Ekso bionics reports third quarter 2025 financial results

San rafael, calif., oct. 28, 2025 (globe newswire) -- ekso bionics holdings, inc. (nasdaq: ekso) (“ekso bionics” or the “company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and nine months ended september 30, 2025.

EKSO Ratings Summary

EKSO Quant Ranking